Dosage variation depends on body mass scaling factors, target purpose (soft tissue recovery focus or tendon repair focus), administration route selection (subcutaneous delivery or intramuscular delivery), and reconstitution concentration, affecting injection volume per dose
[39] A 2025 study in which some Parkinson's patients received exenatide found no evidence that it slowed disease progression or provided any benefit after 96 weeks
J Psychopharmacol (Oxford England)
Supports energy and mental focus
Neuroimaging evidence linking depression and type 2 diabetes mellitus Neuroimaging studies have provided insights into the neural mechanisms linking depression and T2DM, revealing structural and functional brain alterations that may underlie their comorbidity
Supporting Skin Health and Hormonal Acne Many women experience "period skin," which often includes oiliness and cystic acne around the chin and jawline